Literature DB >> 2957109

Long-term control of Chagas disease in Venezuela: effects on serologic findings, electrocardiographic abnormalities, and clinical outcome.

H Acquatella, F Catalioti, J R Gomez-Mancebo, V Davalos, L Villalobos.   

Abstract

To evaluate the long-term effects (20 years) of a Chagas control program (CCP) in Venezuela, a prospective serologic evaluation was carried out from 1981 to 1984 on 5771 inhabitants (8%) of Roscio county. This region was selected as a representative area where the national CCP was implemented effectively. Comparison with a serologic survey performed in the same region before the CCP disclosed a reduction in seropositive subjects from 47.8% to 17.1% (p less than .001), most marked amongst children and teenagers from 29.9% to 1.9%, suggesting that transmission of the disease had diminished. Similar seropositivity changes after the CCP were observed nationwide. Because decreased superinfection would also be expected to occur, we tried to ascertain whether the clinical outcome of seropositive individuals living in Roscio county had improved. The mean age of seropositive subjects between both surveys increased significantly from 34.9 +/- 17.3 to 46.7 +/- 15.1 years (p less than .001). Additionally, we examined clinically and obtained electrocardiograms from 775 seropositive subjects. They were classified as asymptomatic (group A, n = 614) or as symptomatic, having mild-to-moderate heart symptoms (group B, n = 99) or having advanced congestive heart failure (group C, n = 62). Their electrocardiograms were compared with those of 923 seronegative subjects collected simultaneously and with published data obtained before the CCP. Comparison of the age-related rates of electrocardiographic abnormalities of seropositive individuals before and after the CCP showed that they did not differ significantly by linear regression analysis, by the Kruskal-Wallis test, or by the normal approximation to the binomial distribution.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957109     DOI: 10.1161/01.cir.76.3.556

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  Electrocardiographic and echocardiographic abnormalities in Chagas disease: findings in residents of rural Bolivian communities hyperendemic for Chagas disease.

Authors:  Antonio B Fernandez; Maria Carmo P Nunes; Eva H Clark; Aaron Samuels; Silvio Menacho; Jesus Gomez; Ricardo W Bozo Gutierrez; Thomas C Crawford; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

2.  Chagas cardiomyopathy in the context of the chronic disease transition.

Authors:  Alicia I Hidron; Robert H Gilman; Juan Justiniano; Anna J Blackstock; Carlos Lafuente; Walter Selum; Martiza Calderon; Manuela Verastegui; Lisbeth Ferrufino; Eduardo Valencia; Jeffrey A Tornheim; Seth O'Neal; Robert Comer; Gerson Galdos-Cardenas; Caryn Bern
Journal:  PLoS Negl Trop Dis       Date:  2010-05-18

Review 3.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

4.  Prevalence of Chagas heart disease in a region endemic for Trypanosoma cruzi: evidence from a central Bolivian community.

Authors:  Jessica E Yager; Daniel F Lozano Beltran; Faustino Torrico; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

5.  Sustained Domestic Vector Exposure Is Associated With Increased Chagas Cardiomyopathy Risk but Decreased Parasitemia and Congenital Transmission Risk Among Young Women in Bolivia.

Authors:  Michelle Kaplinski; Malasa Jois; Gerson Galdos-Cardenas; Victoria R Rendell; Vishal Shah; Rose Q Do; Rachel Marcus; Melissa S Burroughs Pena; Maria del Carmen Abastoflor; Carlos LaFuente; Ricardo Bozo; Edward Valencia; Manuela Verastegui; Rony Colanzi; Robert H Gilman; Caryn Bern
Journal:  Clin Infect Dis       Date:  2015-06-09       Impact factor: 9.079

Review 6.  Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy.

Authors:  Claudio A Muratore; Adrian Baranchuk
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

7.  ECG manifestations of the biggest outbreak of Chagas disease due to oral infection in Latin-America.

Authors:  Juan Marques; Iván Mendoza; Belkisyolé Noya; Harry Acquatella; Igor Palacios; María Marques-Mejias
Journal:  Arq Bras Cardiol       Date:  2013-07-26       Impact factor: 2.000

8.  The role of haptoglobin genotypes in Chagas disease.

Authors:  Ninomar Mundaray Fernández; Mercedes Fernández-Mestre
Journal:  Dis Markers       Date:  2014-07-24       Impact factor: 3.434

9.  Mortality among blood donors seropositive and seronegative for Chagas disease (1996-2000) in São Paulo, Brazil: A death certificate linkage study.

Authors:  Ligia Capuani; Ana Luiza Bierrenbach; Airlane Pereira Alencar; Alfredo Mendrone; João Eduardo Ferreira; Brian Custer; Antonio Luiz P Ribeiro; Ester Cerdeira Sabino
Journal:  PLoS Negl Trop Dis       Date:  2017-05-18

10.  Baroreflex sensitivity and its association with arrhythmic events in Chagas disease.

Authors:  Astrid Meireles Santos; Mauricio Ibrahim Scanavacca; Francisco Darrieux; Bárbara Ianni; Sissy Lara de Melo; Cristiano Pisani; Francisco Santos Neto; Eduardo Sosa; Denise Tessariol Hachul
Journal:  Arq Bras Cardiol       Date:  2014-05-27       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.